Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Polychemotherapy

Known as: Polychemotherapies 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The interplay between a non-lethal autophagic response and apoptotic cell death is still a matter of debate in cancer cell… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Antitumor therapy of hematological malignancies is impeded due to the high toxicity of polychemotherapy toward liver and… Expand
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
AIM OF THE STUDY Non-response (NR) to treatment of childhood relapsed acute lymphoblastic leukaemia (ALL) is an end-point of… Expand
Is this relevant?
2009
2009
I n contrast with most primary cutaneous B-cell lymphomas, primary cutaneous large B-cell lymphomas, leg type (PCLBCLs-LT) are… Expand
Is this relevant?
2004
2004
Moderate intensification of conventional multicycle chemotherapy has recently been shown to improve treatment results in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2004
Review
2004
The taxanes and anthracyclines have emerged as the most active agents for treating women with advanced breast cancer. As such… Expand
  • table 1
  • table 2
Is this relevant?
Review
2001
Review
2001
Among the novel chemotherapeutic drugs introduced in the 1990s, the taxanes have emerged as the most powerful compounds in breast… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
1996
1996
PURPOSE Venous access ports (VAPs) can be used to administer polychemotherapy to patients with malignancies. The purpose of this… Expand
  • table 2
  • table 4
Is this relevant?
1993
1993
Aims and background Patients with disseminated gastric cancer are generally in very bad clinical conditions, which make them not… Expand
  • table 1
  • table 2
Is this relevant?
1986
1986
20 patients with F.I.G.O. stages III ovarian cancer were entered into a randomised trial between January 1980 and March 1984… Expand
Is this relevant?